25th Annual San Antonio Breast Cancer Symposium, San Antonio, Texas, USA, 10–14 December 2002 Update on clinical research

doi:10.1186/bcr576

Breast Cancer Res

Volume 5
Issue 2

Viewing options:

Abstract
Full text
PDF (46KB)

Associated material:

Related literature:

Articles citing this article
on BioMed Central
on Google Scholar
on PubMed Central
Other articles by authors
on Google Scholar

Ring A
Head J

on PubMed

Ring A
Head J
Related articles/pages
on Google

on Google Scholar

on PubMed

Tools:

Post to:

Meeting report

25th Annual San Antonio Breast Cancer Symposium, San Antonio, Texas, USA, 10–14 December 2002 Update on clinical research

Alistair Ring and Julia Head

Breast Unit, Department of Medicine, Royal Marsden Hospital, London, UK

author email corresponding author email

Breast Cancer Res 2003, 5:113-116doi:10.1186/bcr576


Published:	5 February 2003

Abstract

The Annual San Antonio Breast Cancer Symposium has become a key forum for the presentation and discussion of both translational scientific aspects as well as clinical aspects of breast cancer care. In this report of the 25th Annual Meeting, an update of the salient clinical data is presented. The findings of the CALGB 9741 trial, an updated analysis of the Arimidex, Tamoxifen, Alone or in Combination study, and other significant paper and poster presentations are discussed. Summaries are also given of the clinical plenary lectures and minisymposia on adjuvant therapy and aromatase inhibitors.